Literature DB >> 24431686

Endometrial hyperplasia: a clinicopathological study in a tertiary care hospital.

Gargi Raychaudhuri1, Anjali Bandyopadhyay2, Dipnarayan Sarkar3, Sarbeswar Mandal3, Sajeeb Mondal4, Pradip Kumar Mitra5.   

Abstract

OBJECTIVE: To evaluate the clinical as well as histomorphologic features in different cases of endometrial hyperplasia along with its relative occurrence.
MATERIALS AND METHODS: A one-and-a-half-year prospective study was conducted on histopathologically diagnosed cases of endometrial hyperplasia in a tertiary care hospital. Apart from relevant clinical findings, histomorphologic details were noted and statistically analyzed. OBSERVATIONS: Maximum number (46.5 %) of endometrial hyperplasia occurred in patients of 41-50 years age group. Majority (55.2 %) of the patients were found to be premenopausal. Menorrhagia was the most common (49.6 %) clinical presentation followed by postmenopausal bleeding (30.8 %). Simple hyperplasia without atypia was the most common type (95.6 %) followed by complex hyperplasia without atypia (3.6 %) and complex hyperplasia with atypia (0.8 %), respectively. The study of gland-stroma ratio revealed 65:35 to be the most frequent (34 %) ratio; variable-sized glands with cystic dilatation (60.4 %) was the commonest gland architecture and most of the cases (99.2 %) showed the absence of atypia. Associated histopathological findings included a case each of endometrial adenocarcinoma and undifferentiated endometrial stromal sarcoma along with the common leiomyoma and progesterone effects.
CONCLUSION: Menorrhagia was the most common presenting complaint in cases of endometrial hyperplasia. The cases were mostly in the premenopausal age group. Simple endometrial hyperplasia without atypia was the commonest type diagnosed histopathologically. Histopathological examination along with clinical details is essential to give the final opinion regarding the diagnosis.

Entities:  

Keywords:  Endometrium; Hyperplasia; Menorrhagia

Year:  2013        PMID: 24431686      PMCID: PMC3889273          DOI: 10.1007/s13224-013-0414-2

Source DB:  PubMed          Journal:  J Obstet Gynaecol India        ISSN: 0975-6434


  9 in total

1.  Histological effects of progestins on hyperplasia and carcinoma in situ of the endometrium.

Authors:  R W KISTNER
Journal:  Cancer       Date:  1959 Nov-Dec       Impact factor: 6.860

2.  Menstrual irregularities with excessive blood loss: a clinico-pathological correlation.

Authors:  Muhammad Muzaffar; Khalida Adeeb Khanum Akhtar; Shahina Yasmin; Wasim Iqbal; Masood Ahmed Khan
Journal:  J Pak Med Assoc       Date:  2005-11       Impact factor: 0.781

3.  Incidence of endometrial hyperplasia in 100 cases presenting with polymenorrhagia/menorrhagia in perimenupausal women.

Authors:  Amera Takreem; Nargis Danish; Sadia Razaq
Journal:  J Ayub Med Coll Abbottabad       Date:  2009 Apr-Jun

4.  Endometrial intraepithelial neoplasia (EIN): will it bring order to chaos? The Endometrial Collaborative Group.

Authors:  G L Mutter
Journal:  Gynecol Oncol       Date:  2000-03       Impact factor: 5.482

5.  Endometrial hyperplasia in young women.

Authors:  D L Chamlian; H B Taylor
Journal:  Obstet Gynecol       Date:  1970-11       Impact factor: 7.661

6.  Risk of progression in complex and atypical endometrial hyperplasia: clinicopathologic analysis in cases with and without progestogen treatment.

Authors:  L-C Horn; U Schnurrbusch; K Bilek; B Hentschel; J Einenkel
Journal:  Int J Gynecol Cancer       Date:  2004 Mar-Apr       Impact factor: 3.437

7.  Biological behavior of preneoplastic conditions of the endometrium: A retrospective 16-year study in south India.

Authors:  Shalinee Rao; Sandhya Sundaram; Raghavan Narasimhan
Journal:  Indian J Med Paediatr Oncol       Date:  2009-10

8.  The behavior of endometrial hyperplasia. A long-term study of "untreated" hyperplasia in 170 patients.

Authors:  R J Kurman; P F Kaminski; H J Norris
Journal:  Cancer       Date:  1985-07-15       Impact factor: 6.860

9.  Endometrial carcinoma risk among women diagnosed with endometrial hyperplasia: the 34-year experience in a large health plan.

Authors:  J V Lacey; O B Ioffe; B M Ronnett; B B Rush; D A Richesson; N Chatterjee; B Langholz; A G Glass; M E Sherman
Journal:  Br J Cancer       Date:  2007-11-20       Impact factor: 7.640

  9 in total
  3 in total

1.  Immunohistochemical Study of ER, PR, Ki67 and p53 in Endometrial Hyperplasias and Endometrial Carcinomas.

Authors:  Nayar Musfera Abdul Masjeed; Siddhi Gaurish Sinai Khandeparkar; Avinash R Joshi; Maithili Mandar Kulkarni; Nidhi Pandya
Journal:  J Clin Diagn Res       Date:  2017-08-01

2.  Endometrial hyperplasia-related inflammation: its role in the development and progression of endometrial hyperplasia.

Authors:  A V Kubyshkin; L L Aliev; I I Fomochkina; Ye P Kovalenko; S V Litvinova; T G Filonenko; N V Lomakin; V A Kubyshkin; O V Karapetian
Journal:  Inflamm Res       Date:  2016-06-16       Impact factor: 4.575

3.  Turner syndrome with Xp deletions and rare endometrial abnormalities: A case report.

Authors:  Lei Liang; Libin Mei; Yingying Shi; Lingling Huang; Zhiying Su; Yu Zeng; Haijie Gao; Xuemei He; Hui Huang; Yanru Huang; Ping Li; Jing Chen
Journal:  Medicine (Baltimore)       Date:  2021-11-19       Impact factor: 1.889

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.